Alba, George A.
Atri, Deepak
Darbha, Sriranjani
Singh, Inderjit
Tapson, Victor F.
Lewis, Michael I.
Chun, Hyung J.
Yu, Yen-Rei
Maron, Bradley A.
Rajagopal, Sudarshan https://orcid.org/0000-0002-3443-5040
Funding for this research was provided by:
American Heart Association (19TPA34880033)
Article History
Accepted: 27 April 2021
First Online: 19 August 2021
Declarations
:
: Dr. Tapson reports grants from Bayer, and grants and personal fees from Janssen and Actelion, outside the submitted work.Dr. Maron reports personal fees from Actelion, outside the submitted work. In addition, Dr. Maron has a patent US patent 9,605,047 issued, a patent US pending patent PCT/US2019/059890 pending, and patent applications 62475955 and 029672 pending.Dr. Rajagopal reports grants and personal fees from Janssen and United Therapeutics, and personal fees from Altavant, Apie Therapeutics, Bayer, Insmed, and Liquidia Technologies, outside the submitted work. In addition, Dr. Rajagopal has a patent US Patent 62/673,175. “Dynamic 129Xe Gas Exchange Spectroscopy” licensed to Polarean Corporation.The other authors declare that they have no conflict of interest.
: This article does not contain any studies with human or animal subjects performed by any of the authors.